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INTRODUCTION 
       
Regional anesthesia as the name implies is the blocking of peripheral nerve 
conduction in a reversible manner by using local anesthetic agents, thereby one 
region of the body is made insensitive to pain and is devoid of reflex response to 
surgical stimuli.  The central nervous system is spared, so the patient is conscious 
during the surgical procedure. 
       Regional anesthesia offers many advantages over general anesthesia1-5 for 
surgery on upper extremities, particularly in emergency operations. 
 
Advantages of Regional over General anesthesia: 
• Causes least disturbance to the normal physiology than any other type of 
anesthesia.  
• Proven to be safe for high risk patients who are in greater risk due to the 
stress imposed by general anesthesia. 
• Only method of anesthesia, which prevents all afferent impulses from the 
site of surgery from reaching the CNS.  Hence the need for polypharmacy 
and its attended risks are eliminated. 
• Along with complete pain relief and total muscle relaxation it produces 
vasodilatation, which improves blood circulation and prevents tissue 
hypoxia. 
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• Many intraoperative and postoperative complications of general anesthesia 
are avoided. 
• Postoperative pain relief is ensured for a longer duration by using long 
acting local anesthetic drug and for several days if continuous block using 
catheter technique is employed. 
• It is cost effective and safe. 
• Avoids theatre pollution. 
• Safest technique for patients with full stomach. 
• All the adverse effects of airway manipulation can be avoided. 
 
      The frequent use of pneumatic tourniquet33 to provide a bloodless field 
during surgery makes individual nerve blocks impractical.  Brachial plexus block6 
is the answer in such a situation.  There are different approaches but the ones 
frequently employed for blocking the brachial plexus2 include 
a) Supraclavicular approach 
b)  Infraclavicular approach 
c) Axillary approach 
d) Interscalene approach 
 
          Axillary approach16 has the lowest incidence of serious complications and 
can be performed with ease.  But there are limitations associated with axillary 
approach8-10 like 
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• It is inadequate for operations on the arm and shoulder. 
• It is difficult to block the musculocutaneous nerve predictably with 
resultant sparing of the radial aspect of forearm and dorsum of hand. 
• Tourniquet pain is not well tolerated. 
• Also abducting the arm by 90 degrees for giving the block may be 
painful and even dangerous in traumatic lesions of the upper extremity. 
 
          The brachial plexus is approached at the level of trunks and the compact 
arrangement of trunks at supraclavicular level gives a high success rate with 
minimum local anesthetic drug volume and a dense & fast onset block. Hence the 
supraclavicular approach is the method of choice for blocking the brachial plexus2 
. 
      William Steward Halsted first performed brachial plexus block in 1885.  In 
1911, Kulenkampff and Hirshel described the first percutaneous brachial plexus 
block by supraclavicular and axillary routes respectively. 
 
     Since then several techniques of brachial plexus block have been described 
with the purpose of improving the efficacy and success rate and minimizing the 
risk and rate of complications.  Of the various techniques2 the most widely 
practiced methods are the classical technique described by Patrick (1940), Vertical 
plumb bob approach described by Brown, 1st rib walk over technique described by 
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Bonica and Moore and the Subclavian perivascular technique described by Winnie 
and Collins (1964). 
       Of the several local anaesthetic drugs used for brachial plexus block, 
Bupivacaine is used most frequently in our set up as it has a long duration of 
action varying from 3 – 8 hours16,32,38,43.   
 
       To prolong the duration of analgesia various drugs have been studied as 
adjuvant to the local anaesthetic solution and techniques like the continuous 
catheter placement in the plexus have evolved.  These adjuvant drugs ideally are 
expected to prolong the analgesic effect without causing any systemic side effects 
or prolonging motor blockade.  Commonly used additives to local anesthetic 
solution are epinephrine, clonidine and opioids1,2. 
 
      Midazolam, a water soluble benzodiazepine, is known to produce 
antinociception71,72 and to enhance the effect of local anesthetic when given 
epidurally or intrathecally73-80.  Midazolam produces this effect by its action on 
GABA-A receptors71,76,80.  The presence of GABA receptors in peripheral nerves 
is also demonstrated67,69,81.   
 
      This study is intended to determine the effects of adding midazolam to 
Bupivacaine in brachial plexus blockade by supraclavicular approach with regard 
to the onset, intensity and duration of blockade along with its analgesic efficacy. 
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AIM OF THE STUDY 
 
    
    
 
       The aim of the present study is to evaluate the effect of addition of 50µg/kg 
of preservative free Midazolam to 0.5% Bupivacaine solution in supraclavicular 
brachial plexus block on the  
 
• Onset of blockade 
• Duration of blockade  
• Intensity of blockade 
• Sedation  
• Complications if any & 
• Quality of analgesia 
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ANATOMY OF BRACHIAL PLEXUS 11-15 
 
     Knowledge of the formation of the brachial plexus and of its distribution 
is absolutely essential for the precise and effective use of brachial plexus analgesia 
for surgeries of the upper limb.  A thorough understanding of the vascular, 
muscular and fascial relationships of the plexus throughout its formation and 
distribution is equally essential in order to master the various techniques of 
brachial plexus analgesia. 
 
      In its course from the intervertebral foramina to the arm, the fibres that 
constitute the plexus are composed consecutively of roots, trunks, divisions, cords 
and terminal branches, which are formed through a complex process of 
combining, dividing, recombining and finally redividing. 
 
     The brachial plexus is formed by the union of the anterior primary rami of 
the fifth to eighth cervical nerves and first thoracic nerve with occasional 
contributions from the fourth cervical nerve (prefixed) above and second thoracic 
nerve (postfixed) below.  These nerves unite to form trunks, which lie in the neck 
above the clavicle.  Its roots pass through the fascia enclosed space between the 
scalenus anterior and the scalenus medius accompanied by the subclavian artery 
and invaginate the scalene fascia to form a neurovascular bundle.  This fascia 
becomes the axillary sheath in the axilla. 
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Relations of brachial plexus 
 
Anterior relations 
      The skin, superficial fascia, platysma, and supraclavicular branches of the 
superficial cervical plexus, the deep fascia and external jugular vein.  The clavicle 
is in front of the lower part and scalenus anterior is in front of the upper part. 
 
Posterior relations 
      Scalenus medius and the long thoracic nerve of Bell. 
 
Inferior relations 
      Related to the first rib. 
 
Superior relations 
      Lies first above and then lateral to the subclavian artery. 
 
Sympathetic contribution to the plexus 
      Close to their emergence, the 5th and 6th cervical nerves, each receive a grey 
ramus from the middle cervical sympathetic ganglion.  The 7th and 8th cervical 
nerves each receive a grey ramus from the inferior cervical ganglion. 
 14
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Roots 
      Anterior primary rami of C5 – C8 and T1 ( occasionally C4 or T2 ). 
Trunks 
• Upper trunk – anterior rami of C5 and C6 
• Middle trunk – anterior ramus of C7 
• Lower trunk – anterior ramus of C8 and T1. 
Divisions 
     Behind the clavicle each trunk divides into anterior and posterior divisions. 
 
Cords 
• Lateral cord – Anterior divisions of upper and middle trunks (C5 – C7) 
• Medial cord  - Anterior division of lower trunk (C8 – T1) 
• Posterior cord – Posterior divisions of all the three trunks  (C5 – T1) 
 
Branches 
 From Roots 
• Nerve to serratus anterior C5 – C7 
• Muscular branches to longus cervices C5 – C8. 
• Nerve to the three scalene C5 – C8. 
• Nerve to Rhomboids C5 
• A twig to phrenic nerve C5. 
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From Trunks 
• Suprascapular nerve C5 & C6 
• Nerve to subclavius C5 & C6 
From Cords 
• Lateral cord (three): 
            Lateral pectoral C5 – C7 
            Lateral root of the Median C5- C7 
            Musculocutaneous C5 – C7 
• Medial cord ( five ): 
                 Medial root of median nerve C8 – T1 
                Medial pectoral C8 – T1 
                 Medial cutaneous N of forearm C8 – T1 
                 Medial cutaneous N of arm C8 – T1 
                 Ulnar C8 – T1 
• Posterior cord 
                Radial C5 – T1 
                Axillary C5 – C8 
                Thorocodorsal C6 – C8 
                Upper and lower subscapular  C5 – C6 
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Familiarity with the perineural structures that surround and accompany the 
brachial plexus as it leaves the vertebral column on its course to the upper arm is 
as important as the knowledge of the formation and distribution of the neural 
plexus itself.  Palpable muscular and vascular landmarks allow accurate location 
of the plexus percutaneously.  An appreciation of the fascial relations is absolutely 
essential since this is the basis for all the perivascular techniques. 
 
      After leaving the intervertebral foramina, the anterior primary rami of the 
nerves destined to become the brachial plexus travel in the gutter formed by the 
anterior and posterior tubercles of the corresponding transverse processes of the 
cervical vertebrae.  After leaving the transverse process, the roots of the plexus 
descend in front of the middle scalene muscle, which arises from the posterior 
tubercles of the transverse processes of the lower six cervical vertebrae.  The 
insertion of this muscle on the first rib is separated from that of the anterior 
scalene muscle by the inferior trunk of the brachial plexus.  The anterior scalene 
muscle arises from the anterior tubercles of the transverse process of the 3rd – 6th 
cervical vertebrae and inserts on the scalene tubercle of the first rib, thus 
separating the subclavian artery from the subclavian vein. 
 
       The fascia covering both the scalene muscles is derived from the 
prevertebral fascia, which splits to invest these muscles and then fuses again at 
their lateral margins to form an enclosed interscalene space.  Therefore, as the 
roots leave the transverse processes, they emerge between two walls of the fascia  
 18
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 covering the anterior and middle scalene muscles.  In their descent toward the 
first rib to form the trunks of the plexus, the roots may be considered to be 
sandwiched between the anterior and middle scalene muscles, the fascia of which 
serves as a sheath of the plexus.  As the trunks approach the first rib, they are 
arranged ( as their designations – superior, middle and inferior imply )  one above 
the other vertically, not one next to the other horizontally as depicted in so many 
texts. 
 
      As the trunks of the plexus cross the first rib, they are joined by the 
subclavian artery, which lies in a plane anterior to the trunks, so that the inferior 
trunk lies behind the artery in the subclavian groove with the middle and superior 
trunks above the level of the vessel.  At this level the artery and trunks are moving 
laterally; across the ribs and invaginate the scalene fascia to form the subclavian 
perivascular space, which is continuous medially and superiorly with the 
interscalene space and inferiorly and laterally with the axillary perivascular space.  
The important concept is that there is a continuous fascial enclosed 
perineural and perivascular space extending from the cervical transverse processes 
to several centimeters beyond the axilla; this space has been divided into an 
axillary perivascular space and an interscalene space.  The existence of such a 
continuous perineural space renders brachial plexus block simple.  The space 
described may be entered at any level, and the volume of the anesthetic injected at 
that level would determine the extent of anesthesia.  Thus, the technique to be used 
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in any case should be determined on the basis of the surgical site, the required 
level of anesthesia, the physical status and habitus of the patient. 
 
       The upper medial aspect of the arm is not anesthetized by any brachial 
plexus block technique, since this area is innervated by the intercostobrachial 
nerve T2. This nerve can be blocked by subcutaneous infiltration across the upper 
medial aspect of arm using 3-5ml of local anaesthetic solution for surgical 
anesthesia  or tourniquet. 
 
      The brachial plexus can be blocked at the level of the roots, trunks, cords or 
peripheral branches.  The block at each level has a distinct distribution of 
anaesthesia, advantages, disadvantages, and complications. 
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CLINICAL PHARMACOLOGY35-47 
BUPIVACAINE 
 
     Synthesized by Bo Af Evenstam in 1957 in Sweden. 
     First came into clinical use in 1963. 
     Bupivacaine is an anilide compound.   
     It is an amide local anesthetic (1-butyl-N-(2, 6-dimethylphenyl)-piperidine-2-
carboxamide). 
Presentation  
      As a clear 0.25 / 0.5 / 0.75 % solution of bupivacaine hydrochloride.  The 
hyperbaric solution used for subarachnoid block contains 80 mg/ml of glucose.  
Physiochemical properties 
     pKa = 8.1 
     protein binding : 96% 
     lipid solubility : 28 
 
C18H28N2O 
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Mechanism of Action 
          Local anesthetics such as bupivacaine block the generation and the 
conduction of nerve impulses, presumably by increasing the threshold for 
electrical excitation in the nerve, by slowing the propagation of the nerve impulse, 
and by reducing the rate of rise of the action potential. In general, the progression 
of anesthesia is related to the diameter, myelination and conduction velocity of 
affected nerve fibers. Clinically, the order of loss of nerve function is as follows: 
(1) pain, (2) temperature, (3) touch, (4) proprioception, and (5) skeletal muscle 
tone. The analgesic effects of Bupivacaine are thought to be due to its binding to 
the prostaglandin E2 receptors, subtype EP1 (PGE2EP1), which inhibits the 
production of prostaglandins, thereby reducing fever, inflammation, and 
hyperalgesia. 
 
Routes of administration / doses       
      Bupivacaine may be administered topically by infiltration, intrathecally or 
epidurally.  The therapeutic dose of bupivacaine is 2 – 3 mg/kg (with or without 
adrenaline). 
      The drug acts within 10 to 20 minutes and has duration of action of 5 - 6 
hours. 
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Pharmacokinetics 
     The absorption of local anesthetics is related to  
• The site of injection ( intercostals > epidural > brachial plexus > 
subcutaneous ) 
• The dose - a linear relationship exists between the total dose and the peak 
blood concentration achieved. 
• The presence of vasoconstrictors which delay absorption. 
 
     The addition of adrenaline to bupivacaine does not influence the rate of 
systemic absorption as, 
• The drug is highly lipid soluble and therefore uptake into fat is rapid. 
• The drug has a direct vasoconstrictory effect. 
 
      The possible pathways for metabolism of bupivacaine include aromatic 
hydroxylation, N-dealkylation, amide hydrolysis and conjugation.  Only the N-
dealkylated metabolite N-desbutyl bupivacaine has been measured in the blood or 
urine. 
      Alpha 1 acid glycoprotein is the most important protein binding site of 
bupivacaine.  5% of the dose is excreted in the urine as pipcolloxylidine. 16% is 
excreted unchanged.  Clearance is 0.47 l/min and the elimination half life is about 
210 minutes. 
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Systemic toxicity 
 
Cardiovascular system 
      Bupivacaine is markedly cardiotoxic.  It binds specifically to the 
myocardial proteins.  In toxic concentrations the drug decreases the peripheral 
vascular resistance and myocardial contractility producing hypotension and 
possible cardiovascular collapse.  Cardiotoxic plasma concentration of 
bupivacaine is 8-10 ug /ml. 
 
Central nervous system 
      The principal effect of bupivacaine is reversible neural blockade.  This 
leads to a characteristically biphasic effect in the central nervous system.  During 
accidental overdosage or direct vascular injections the clinical signs are numbness 
of tongue, lightheadedness, visual and auditory disturbances, muscular twitching 
and tremors.  The signs may progress to generalized convulsions of the tonic – 
clonic nature.  When plasma levels continue to rise, CNS excitation is rapidly 
superseded by depression.  ( drowsiness, disorientation and coma ) 
 
     The typical plasma concentration of bupivacaine associated with seizures 
is  4.5  to  5.5 µg/ml. 
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MIDAZOLAM 
 
      Midazolam is a water soluble imidazobenzodiazepine ( 8-chloro-6-(2-
fluorophenyl) -1-methyl-4H-imidazo[1,5-a] [1,4]benzodiazepine ) and its unique 
feature being its pH dependent imidazole ring which open at pH < 4 and accounts 
for its stability in aqueous solution and rapid metabolism.  At pH > 4, the ring 
closes leading to increase in lipid solubility. 
 
 
C18H13ClFN3 
 
Pharmacokinetics  
 It has a pH of 3.5 with pKa of 6.15 
 Protein binding : 96 – 98% 
 Volume of distribution : 1 – 1.5 l/kg 
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 Clearance : 6 – 8 ml/kg/min 
 Elimination half time: 1.4 hours. Increased in elderly/obese. 
 Metabolised by hepatic microsomal enzyme cytochrome p – 450 by 
hydroxylation to 1 OH and 4 OH midazolam. 
      Excreted in urine as glucuronide conjugates.  Erythromycin decreases its 
hepatic clearance leading to increased duration of action.  Less than 0.02% is 
excreted unchanged.  Therefore it is not affected by renal failure. 
 
Mechanism of Action 
          It is thought that the actions of benzodiazepines such as midazolam are 
mediated through the inhibitory neurotransmitter gamma-aminobutyric acid 
(GABA), which is one of the major inhibitory neurotransmitters in the brain. 
Benzodiazepines increase the activity of GABA, thereby producing a calming 
effect, relaxing skeletal muscles, and inducing sleep. Benzodiazepines act as 
agonists at the benzodiazepine receptors, which form a component of the 
benzodiazepine-GABA receptor-chloride ionophore complex. Most anxiolytics 
appear to act through at least one component of this complex to enhance the 
inhibitory action of GABA. 
 
Dosage and Routes of Administration : 
Routes 
      Oral, nasal, intramuscular, intravenous, intrathecal and epidural. 
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Dosage 
     Sedation           : 0.05 – 0.1 mg/kg 
     Premedication  : 0.07 – 0.08 mg/kg 
     Induction          : 0.1 – 0.3 mg/kg 
     Infusion            : 2 – 5 mcg/kg/min 
     Intrathecal        : 0.3 – 2 mg 
     Epidural           : 0.1 – 0.2 mg/kg 
Actions 
Central nervous system 
      Decreases cerebral blood flow, cerebral oxygen requirement and 
intracranial pressure. 
      Sedation, hypnosis, anxiolysis 
      Anterograde amnesia 
      Anticonvulsant 
 
Respiratory system 
      Transient apnoea occurs when administered in doses greater than 0.15 
mg/kg and in opiod premedicated subjects. 
      Potent respiratory depressant especially in chronic obstructive pulmonary 
disease patients. 
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Cardiovascular system 
      Decrease in peripheral vascular resistance and transient attenuation of 
baroreceptor reflexes leading to hypotension and tachycardia.  In hypovolemic and 
elderly patients there is increased risk of significant hypotension. 
Local effects 
      No venous irritation and thrombophlebitis.  
 
Mechanism of pain relief in central neuraxial blockade 
      It acts on spinal GABA receptors.  There are 2 types of GABA receptors: 
GABA-A and GABA-B.  Midazolam binds to the alpha subunit of the pentamer 
GABA-A receptor leading to its conformational change causing increased chloride 
ion conductance and hyperpolarisation and thereby acts by potentiating the 
inhibitory neurotransmitter, GABA.  This is mainly a postsynaptic action while 
GABA-B receptors mainly have presynaptic antinociceptive effect by decreasing 
the excitatory neurotransmitter release. 
      Intrathecal midazolam positively modulates GABA-A / benzodiazepine 
receptor complex causing the release of an endogenous opioid acting at opioid 
receptors and also intrathecal midazolam causes antinociception by combining 
with three different receptor subtypes of GABA-A in the spinal cord. 
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PHARMACOKINETICS OF LOCAL ANESTHETICS IN 
BRACHIAL PLEXUS BLOCKADE34 
 
     When a local anesthetic is injected around a nerve trunk, it will soak the 
trunk in an advancing front.  Transmission in fibers situated in the periphery of the 
trunk (mantle fibres) will be first blocked and those in the centre of the trunk (core 
fibres) last.  Further, transmission in peripherally placed fibres will be blocked 
over a longer length of time compared to central fibres.  Thus analgesia will 
appear first and last longest in the territory supplied by the peripheral fibres.  If the 
pool of local anesthetics is small or if the injection was not accurate or too dilute, 
the fibres in the centre of the trunk will escape blockade. 
 
Theory of Winnie 
 
      The trunks are arranged so that the central fibres are the longest supplying 
the extremities of the limb while shorter fibres are arranged more peripherally as 
their area of supply is more proximal.  Winnie groups the fibres into two: the 
peripheral mantle fibres which contain the motor fibres and core fibres which are  
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mainly inner sensory.  Peripheral motor fibres supply the muscles of the forearm 
and the central fibres carry sensation from the hand.  
 
 Thus the onset of block in the limb is as follows: 
• Loss of motor power to the shoulder and upper arm 
• Loss of sensation on the upper arm 
• Loss of motor power of the forearm 
• Loss of sensation to the hand. 
       
     So the spread of block is from proximal to distal. 
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REVIEW OF LITERATURE 
 
Technique and drug: 
 
Winnie & Collins16 described the subclavian perivascular technique. 
 
          McGlade et al.43, Hickey et al.44 compared the effectiveness of 0.5% 
ropivacaine and 0.5% bupivacaine for brachial plexus block. They appeared 
equally effective in providing brachial plexus anesthesia. 
 
Peripheral GABA  receptors:  
The presence of peripheral GABA receptors is suggested by the following 
studies: 
Brown et al.67,68 observed that extrasynaptic GABA-receptors occur on both 
neurone somata and unmyelinated axons in the mammalian peripheral nervous 
system. Activation of these receptors leads to depolarization, reduced spike 
amplitude and slowed conduction, probably mediated through increased 1. Cl- 
conductance. 2. GABA also depolarizeds preganglionic nerve terminals in the rat 
superior cervical ganglion and reduces the release of acetylcholine by 
preganglionic nerve impulses. 3. The Schwann and satellite neuroglial cells 
surrounding peripheral unmyelinated axons and neurones possess a GABA-carrier 
 32
promoting net uptake of GABA at external concentrations greater than or equal to 
1 microM. 4. The possible significance of extrasynaptic receptors and carriers for 
GABA is discussed. 
 
Bhisitkul et al69 used a sucrose gap chamber to study the effect of gamma-
aminobutyric acid (GABA) on normal and regenerating rat peripheral nerve fibers. 
The results indicate that GABA receptors are selectively present on normal 
mammalian sensory axons, and are reestablished on regenerated sensory axons. 
 
Cairns et al.70 suggest that GABAA receptors are located within the TMJ 
region and that their activation appears to attenuate the nociceptive reflex response 
that can be evoked from this region. 
 
Intrathecal midazolam: 
 
Batra et al.83 observed that addition of midazolam to bupivacaine 
intrathecally provided better post-operative analgesia without any adverse effects. 
 
Bharti et al.75 found out that addition of intrathecal midazolam to 
bupivacaine significantly improves the duration and quality of spinal anaesthesia 
and provides prolonged perioperative analgesia without significant side-effects. 
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Yegin et al.74 demonstrated the use of intrathecal midazolam combined with 
intrathecal bupivacaine producing a more effective and longer analgesia with a 
mild sedative effect in perianal surgery. 
 
Kim et al.80 observed that intrathecal midazolam increases the analgesic 
effects of spinal blockade with bupivacaine in patients undergoing 
haemorrhoidectomy.   
 
Epidural midazolam: 
 
Nishiyama et al.76,79 observed that adding midazolam increased not only 
analgesic but also sedative effect with increasing dose of bupivacaine in a 
postoperative continuous epidural administration. 
 
Nishiyama et al.78 observed that adding midazolam (10 to 20 mg per 12 h) 
to continuous epidural infusion of bupivacaine for postoperative pain can provide 
a better analgesia, amnesia and sedation than bupivacaine alone. 
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Caudal Midazolam: 
 
          Gulec et al.82 found that a Bupivacaine and midazolam combination 
prolonged postoperative analgesia compared to a bupivacaine-morphine 
combination when administered caudally. 
 
Midazolam in brachial plexus: 
 
          Koj Jarbo et al.90 observed that midazolam in combination with 
Bupivacaine hastened onset of sensory and motor block, and improved 
postoperative analgesia when used in brachial plexus block, without producing 
any adverse events. 
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MATERIALS AND METHODOLOGY 
 
      Forty adult patients of both sexes in the age group of 20 – 60 years 
belonging to ASA I / II category and their weight ranging between 50 – 70 kgs, 
posted for various types of upper limb surgeries at the Department of Plastic 
Surgery, Institute of Research and Rehabilitation of Hand, Government Stanley 
Hospital, formed the study group. 
 
       This study was designed as a prospective, randomized comparative study.  
After receiving the institutional ethical committee approval and informed  consent,  
the patients were randomly allocated into two groups.  Supraclavicular brachial 
plexus was performed via subclavian perivascular technique. 
 
GROUPS 
 
1. BM - 20 patients received 30 ml of 0.5% Bupivacaine with preservative   
free Midazolam 50 µg/kg.  
2. B      - 20 patients received 30 ml of 0.5% Bupivacaine alone. 
 
Inclusion criteria 
 
• ASA I & II  
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• Age group 20 – 60 years. 
• Weight 50 – 70 kilograms. 
• Surgeries of forearm and hand 
 
Exclusion criteria 
• Patient refusal  
• Coagulopathy 
• Infection at injection site 
• Pneumothorax  or previous pneumonectomy on the opposite side. 
 
      Patients were all preoperatively evaluated, clinically examined and 
investigations done prior to assessment.  Procedures were explained in detail and 
written consent obtained. 
 
      The procedure was carried out in the preparation room or in the theatre 
were facilities for resuscitation were available. 
 
Equipment 
• Sterile tray 
• Sterile towel 
• 2 nos. sterile cups 
• 2 nos. 20 ml glass syringes 
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• 1 no 2 ml syringe 
• sterile gloves 
• sterile swabs 
• sponge holding forceps 
• Betadine solution 
 
Appropriate needles 
     1 no. 24G, 3.75 cms long needle. 
     1 no. 22G, 4cm long, short beveled blunt needle 
 
Drugs 
      0.5% Bupivacaine vial 
      Preservative free Midazolam ampoule 5mg/ml. 
 
Intraoperative and postoperative monitors 
• Pulseoximeter 
• NIBP 
• ECG 
 
      Initially the pre procedure parameters were recorded i.e. pulse rate, BP, 
SpO2 and Ecg.  Then the block was administered.  All through the study these 
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parameters were monitored continuously except the NIBP which was recorded 
intermittently.  Postoperatively they were monitored for 24 hours.   
 
      Patients were observed vigilantly for development of various complications 
and necessary instructions given. 
 
Subclavian Perivascular Technique 
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Position 
• Patient placed in supine position with head turned to the side opposite to 
the side that is to be injected. 
• The arms are at the patient’s side with the hands pointing towards the knee. 
• The arm on the side to be injected may be pulled to depress the clavicle and 
the shoulder. 
• A rolled towel is placed lengthwise between the shoulders along the spine 
to give the best exposure to the area. 
 
Landmarks 
• The anaesthesiologist stands at the head end of the table. 
• The patient is asked to lift the head slightly to bring the clavicular head of 
the sternomastoid muscle into prominence. 
• The index finger is placed lateral to the muscle and the patient is told to 
relax.  Roll the index finger laterally across the belly of the muscle until the 
interscalene groove is palpated. 
• The finger is then moved inferiorly down the groove until the pulse of the 
subclavian artery is palpated between the scalene muscles. 
• After aseptic preparation, a skin wheal is raised at this point with 2ml of 
lignocaine with a 24G needle about 2 - 3 cms above the midpoint of and 
perpendicular to the clavicle. 
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• The pulsation of the subclavian artery against the palpating finger or needle 
is the surest guide to supraclavicular block. 
• The needle enters at the level of C7 in the interscalene groove. 
• The needle is directed caudally and the hub is in line with the ear. 
 
Procedure 
• After a sterile preparation of the region, the 22G, 4cm needle is inserted 
through the skin wheal and above the palpating finger immediately lateral 
to the subclavian artery. 
• It is directed dorsolaterally and parallel to the scalene muscles and towards 
the patient’s feet. There will be a click once the sheath is entered and there 
will be a give way. 
• The needle advancement is stopped at this level and conducted subclavian 
pulsation is observed. If the needle is pulsating then the anaesthetic solution 
is injected. 
• If the needle pulsation is not satisfactory then the needle is advanced further 
till it hits one of the three trunks of the plexus. 
• A paraesthesia to any part of the upper extremity as long as it is below the 
shoulder indicates that the needle is in the perivascular space. 
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• In this technique paraesthesia is obtained before the first rib is contacted.  If 
paraesthesia is not elicited then the needle is withdrawn and tried once 
again. 
• A cough by the patient is a warning that the pleuron is being irritated by the 
needle. 
 
      When the desired endpoint is reached, (  i.e. paraesthesia elicited in the arm 
and fingers or loss of resistance with “ click “ sensation and transmitted pulsations 
is observed as needle movement ) the needle is halted.  Success now depends on 
holding the needle tip near the nerve during the injection.  Potential pitfalls include 
patient movement and failure to hold the needle firmly in place. 
 
      The local anaesthetic solution is injected once the position of needle within 
the sheath is confirmed. 
 
     If there is shooting pain when injecting or if blood is aspirated when 
injecting, the needle is removed and tried once again.  This prevents the 
complications of accidental trauma to the nerve or accidental intravascular 
injection respectively.  Repeated aspiration after injecting 3-5 ml of anaesthetic 
solution ensures that the tip is not in the vessel.  After injecting the local 
anaesthetic, the block is tested for both sensory ( using  pin prick ) and motor ( 
using muscle power ) and is compared with the same stimulation or power in the 
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contralateral arm.  Motor block was evaluated by thumb abduction (Radial nerve), 
thumb adduction ( Ulnar nerve ), thumb opposition ( Median nerve ) and flexion 
of the elbow in supination and pronation of the forearm ( musculocutaneous ). 
 
      The Hollmens scale is used in the study for assessing both sensory and 
motor blockade. 
 
Hollmen’s scale 
Sensory blockade(Grade) 
1. 0 – Normal sensation of pin prick. 
2. + - Pin prick felt as sharp pointed but weaker compared with the same area 
in other extremity. 
3. ++ - Pin prick felt as touch with blunt object. 
4. +++ - No perception of pin prick. 
         Onset of blockade means minimum grade 2 and complete blockade means 
minimum grade 3. 
 
Motor blockade(Grade) 
1. 0 – Normal muscle function 
2. + - Slight depression in muscle function as compared with pre anaesthetic 
power.  
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3. ++ - Very weak muscular action persisting in muscle. 
4. +++ - Complete block with absent muscular function. 
          Onset of blockade means minimum grade 2 and complete blockade means 
minimum grade 3. 
 
Nerves studied in the block 
Sensory 
     Lateral cutaneous nerve of arm 
     Medial cutaneous nerve of arm 
     Medial cutaneous nerve of forearm 
     Posterior cutaneous nerve of forearm 
     Lateral cutaneous nerve of forearm 
     Median nerve 
     Ulnar nerve  
     Radial nerve 
Motor 
     Median nerve 
     Ulnar nerve 
     Radial nerve 
     Musculocutaneous nerve 
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      Evaluation was carried for every minute after completion of the injection 
and the time of onset was noted for both sensory and motor blockade. 
      Onset of blockade, both sensory and motor is defined as a minimum of 
grade 2 in Hollmen’s scale. 
      Blockade was considered complete when sensory and motor scores were at 
least grade 3 in Hollmen’s scale.  Only patients with complete motor block were 
included in the study. 
      Once block was complete, the patient was wheeled into the theatre and 
surgery was allowed to proceed. 
      Duration of sensory blockade was considered as the time interval between 
the local anaesthetic administration and the onset of paraesthesia (during recovery) 
while duration of motor block was defined as the time interval between the local 
anaesthetic administration and the recovery of motor block. 
      Sedation was assessed using the sedation score described by Culebras et 
al.62 where sedation was graded on a scale of 1 to 5 as follows: 
1. awake and alert 
2. sedated, responding to verbal stimulus 
3. sedated, responding to mild physical stimulus 
4. sedated, responding to moderate or severe physical stimulus 
5. not arousable. 
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Monitoring 
      Monitoring during regional anaesthesia focuses on delayed local 
anaesthetic toxicity from excessive tissue absorption (usually 40 – 60 min), 
ventilation and oxygenation and the consequences of surgical stress such as 
tourniquet pain or blood loss. 
      Baseline vital signs PR/RR/BP/SpO2 were recorded and monitored every 5 
min till the procedure was over and thereafter every hour for 24 hours 
postoperatively. 
      Onset, completion of blockade, duration of blockade was assessed as 
described earlier. 
     Pain was assessed using a numerical rating pain score scale where 0 
represents no pain and 10 means the worst possible pain. (VAS scale) 
 
   Statistics  
      Sample size of 20 per group was adequate for the present study. 
      Demographic variables in qualitative form were analysed using the Pearson 
Chi – Squared test and quantitative form data ( weight, age ) were analysed using 
the Student independent t-test. 
      Clinical data like onset, completion, duration & intensity of blockade were 
analysed using the Student independent t-test. 
  Statistical significance with regard to sedation was analysed with Pearson 
Chi-Squared test.  P value < 0.05 was taken as statistically significant. 
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OBSERVATIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
       The mean age in BM group was 30.45 years + 10.9 SD and in the B group it 
was 31.8 years + 10.48 SD. 
     The mean weight in BM group was 58.15 kgs +7.95 SD and in the B group it 
was 59.2 kgs + 5.26 SD.  
     Sex distribution in each group: 16 males and 4 females. 
     The mean duration of surgery was comparable between the two groups: 94 + 
17.52 mins in Group BM and 91 + 16.2 mins in Group B. 
     Thus the demographic profile was comparable between the two groups. ( p 
value = NS ). 
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The mean time of onset of motor block in  
Group BM   :   4.25 + 1.25 mins  
Group B      :  5.4 + 1.27 mins 
      The onset of motor blockade was statistically significant in BM group.       
(  t = 2.88, p = 0.001 ).   
      The onset time of sensory block in  
Group  BM  :  8.4 + 1.5 mins 
Group   B     :  10  + 1.37 mins 
      The onset of sensory blockade was statistically significant in BM group. ( t 
= 3.51, p = 0.001 ).  Motor blockade occurred earlier than sensory blockade in 
both the groups ( p < 0.05 ). 
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    The mean time for complete motor block was  
Group BM  :  19.2 +  4.54 mins 
Group  B     :  17.25 + 2.63 mins 
      The mean time for complete sensory block was 
Group BM  :  22.4 +5.80 mins 
Group  B     :  20.5 + 2.50 mins 
      There was no statistically significant difference in the time taken for 
complete motor ( t = 1.66, p = 0.1) and sensory blockade ( t = 1.34, p = 0.18 )  
between the two groups. 
 
COMPLETE BLOCKADE (p = ns)
19.2
22.4
17.25
20.5
0
5
10
15
20
25
MOTOR SENSORY
M
EA
N
 D
U
R
AT
IO
N
 (m
in
)
BM
B
 50
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
The mean total duration of motor blockade was  
Group BM  :  317.2 + 31.08 mins 
Group B      :  300.9 +26.01 mins 
      The mean total duration of motor blockade was not statistically significant.  
( t = 1.8, p = 0.08 ) 
      The mean total duration of sensory blockade was  
Group BM  :  372.1 +35.96 mins 
Group B      :  331.2 + 33.54 mins 
      The mean total duration of sensory blockade was statistically significant     
( t = 3.72, p = 0.001).  
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INTENSITY OF BLOCKADE 
 
 
 Grading Group BM Group B 
4 14 (70 %) 17 (85 %) 
3 5  (25 %) 3  (15 %) 
2 1  (5 %) 0 
MOTOR 
1 0 0 
4 15 (75 %) 13 (65 %) 
3 5  (25 %) 7  (35 %) 
2 0 0 
SENSORY 
1 0 0 
 
Intensity of Motor blockade 
      Group BM  -  70% patients had grade 4 motor block while 25% had grade 
3 and 5 % patients had grade 2 motor block. 
      Group B  -  85% patients had grade 4 motor block and 15% patients had 
grade 3 block 
     This was not statistically significant.  (X 2 = 1.79, p = 0.41) 
 
Intensity of Sensory blockade 
      Group BM  -  75% patients had grade 4 sensory block and 25% patients had 
grade 3 sensory block. 
      Group B   -  65% patients had grade 4 sensory block and 35% patients had 
grade 3 sensory block. 
       This was not statistically significant.  (X 2 = 0.48, p = 0.49) 
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SEDATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Sedation scores differed between the two groups during the intraoperative 
period (at 30 min). 
Group BM :  10% patients were sedated and required mild physical 
stimulus to awaken, 30% patients sedated and required verbal stimulus to awaken 
and 60% not sedated. 
Group B :  None of the patients was sedated i.e. all were awake and alert. 
      No patient in BM group required assistance for airway maintenance due 
to sedation.  
     Sedation score achieved during the intraoperative period was 
statistically significant (χ2=21.53, P=0.001). Sedation scores did not differ 
between the groups during the postoperative period.  
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Postoperative pain scores were recorded according to Visual Analog  Scale 
( VAS 0 -10 ) at 6, 12 and 24 hours.  Group BM patients recorded a lower mean 
VAS score than their counterparts.  Likewise the rescue analgesic requirement 
(Inj. Diclofenac sodium 3ml IM ) was lower in BM group ( 4 patients ) compared 
to group B (15  patients).  Both were statistically significant ( p < 0.05 ).  
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COMPLICATIONS 
 
          There was one incidence of arterial puncture without formation of 
hematoma.  Needle was again repositioned and drug administered.  Block was 
successful.  There was no other incidence of 
•  Pneumothorax  
• Neurological deficit 
• Phrenic nerve palsy 
• Horner’s syndrome  
• Oversedation  
• LA toxicity 
 
          Heart rate, blood pressure, oxygen saturation and respiration were 
monitored and were stable.  No differences were noted among the groups both 
during the intraoperative and postoperative period. 
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DISCUSSION 
 
      Brachial plexus blockade offers an excellent alternative technique to 
general anaesthesia in anaesthetising the upper limb for surgical procedures. 
Various approaches for successful performance of these blocks and for reducing 
the complications have been described. 
  
      The technique chosen in this study was the subclavian perivascular 
technique.  In 1964 this technique was described by Winnie17 and it allowed 
accurate percutaneous localisation of the plexus.  He used the concept that there is 
a constant relationship between the anterior and middle scalene muscles, the 
plexus and the first rib and that there is an advantage of the continuity of the 
neurovascular sheath of the brachial plexus.  Winnie’s concept that the roots of the 
plexus were sandwiched between the two scalene muscles and the muscles are 
always found to be inserted in the 1st rib.  Hence he introduced the needle between 
the two muscles and in the direction of the space between them.  Thus by using a 
single needle technique eliciting paraesthesia or vascular pulsation as a guide to 
confirm the needle placement in the space he injected the anaesthetic solution, 
which will be confined to the perineural and perivascular area.  Hence he was 
almost certain of a complete and safe block.  This technique by Winnie was 
anatomically precise and conceptually logical. 
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The role of paraesthesia20-27 is controversial. Various studies have 
concluded that paraesthesia during needle insertion improves the success rate of 
the blocks.  Elicitation of paraesthesia may also pose problems in the form of 
direct neural damage by the advancing needle.  While demonstration of 
paraesthesia may aid in positioning the needle for blockage, it is not absolutely 
essential for the success of the block.  The aid of a nerve locator is definitely 
logical but considering the economy and large number of cases being performed 
under expert guidance our technique seems to be practical. 
 
      The longer acting local anaesthetics (Bupivacaine, Ropivacaine ) have 
been associated with longer latencies and higher failure rates2.  Latency can be 
decreased through the appropriate choice of injection site, higher concentration of 
drug used and appropriate volume.  The efficacy and safety of 0.5% Bupivacaine 
is already proved43-45.  Hence 30 ml Bupivacaine 0.5%  used.     
 
     Various agents like epinephrine, opioids, clonidine, neostigmine, 
hyaluronidase and bicarbonate have been used as adjuvants51-64 to local 
anaesthetics in brachial plexus block to quicken the onset, increase the duration 
and enhance the quality of block and also reduce the post operative analgesic 
requirements.  The results have been mixed and at times associated with side 
effects.   
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 Midazolam as an additive to local anaesthetics has been studied in the 
intrathecal, epidural & caudal routes74-80,82,83.  It has been proved in these studies 
that midazolam is as useful additive by way of improved analgesia and with 
sedation. 
 50ug/kg midazolam in central neuraxial blocks did not produce any 
significant adverse effects.    Studies in animals have showed no neurotoxic effects 
of intrathecally administered midazolam85,86,87.  Potentiation of analgesic effects of 
intrathecal fentanyl with midazolam in labouring patients has been demonstrated88. 
Intrathecal midazolam 2 mg did not increase the occurrence of neurologic or 
urologic symptoms89.  Hence this dose (50µg/kg) was chosen in this study. 
 
      In this prospective randomised comparative study, 40 patients satisfying 
the selection criteria underwent brachial plexus block with or without addition of 
preservative free midazolam.  Comparison of onset, completion, duration & 
intensity of blockade, sedation and quality of analgesia between the two groups 
were observed and statistically analysed. 
 
      The onset of sensory and motor blockade was quicker in the BM group.  
This could be due to the synergistic action of midazolam with that of local 
anaesthetics71,76,80. 
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      The onset of motor block was found to be faster than the sensory block 
onset.  This may be attributed to the arrangement of nerve fibers in the trunks as 
described by Winnie34.  Motor fibers are located more peripherally than sensory 
fibers hence a local anaesthetic drug will begin to block motor fibers before it 
arrives at the centrally located sensory fibers. 
 
      Duration of sensory block tended to last longer than motor block in the 
present study.  This is in line with the observations made by de Jong et al32 who 
explained that large fibers require a higher concentration of local anaesthetic than 
small fibers.  The minimal effective concentration of local anaesthetic for large 
(motor) fibers is greater than for small (sensory) fibers.  Thus, motor function 
return before pain perception and duration of motor block is shorter than the 
sensory block. 
 
      In this study, pain scores were significantly lower in patients who received 
Midazolam in addition to Bupivacaine.  The number of patients who required 
rescue analgesia was also lower in this group.  The prolonged analgesia in Group 
BM could be due to the action of midazolam on GABA-A receptors present in the 
brachial plexus and thus producing antinociception.  Various authors have 
demonstrated the presence of GABA receptors in peripheral nerves.  Brown and 
Marsh67 demonstrated GABA receptors in mammalian peripheral nerve trunk.  
Bhisitkul et al.69 showed that axonal GABA receptors are present on both normal 
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and regenerated sensory fibers in rat peripheral nerve.  Cairns et al.70 observed the 
presence of GABA receptors within the temporomandibular joint and that its 
activation could decrease the transmission of nociceptive signals.  The action of 
midazolam on GABA receptors is well established. 
 
      Sedation scores were higher in patients in BM group compared to B group 
during the intraoperative period.  This may be due to partial vascular uptake of the 
drug and its transport to the central nervous system where it acts and produces 
sedation.  The limited duration of sedation could be explained by the fact that 
midazolam is highly lipophilic and diffuses faster into the blood vessels, by its 
rapid clearance ( 6 – 11 ml/kg/min ) and short half life ( 1.7 – 2.6 hr ).  The highest 
sedation score achieved was 3 i.e. the patient was asleep and arousable by mild 
physical stimulus.  No patient experienced airway compromise or required airway 
assistance due to this sedation. 
 
     No complications with regard to the technique or drug was observed.   
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SUMMARY 
 
1. Onset time for both motor and sensory block was quicker in the 
Bupivacaine with midazolam group. 
2. There was no significant difference between the groups in the time taken 
for completion of both motor and sensory blockade. 
3. There was no difference between the groups in the intensity of blockade. 
4. There was no difference between the groups in the mean duration of motor 
blockade. 
5. The mean duration of sensory blockade was significantly prolonged in the 
Bupivacaine midazolam group. 
6. Sedation was statistically significant with Bupivacaine midazolam group in 
the intraoperative period. 
7. There was no complication due to the addition of 50µg/kg Midazolam to 
Bupivacaine. 
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CONCLUSION 
 
 
           In conclusion, midazolam 50µg/kg when used as an additive to 0.5% 
Bupivacaine solution for supraclavicular brachial plexus block, quickens the onset 
of sensory and motor blockade, prolongs the duration of sensory blockade and 
improves the quality of post operative analgesia with mild intraoperative sedation.  
Hence, midazolam can be considered as a safe additive to local anaestetic solution 
for brachial plexus block. 
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GROUP BM – BUPIVACAINE + MIDAZOLAM 
 
 
 
 
 
GROUP B – BUPIVACAINE ALONE 
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